Angina Clinical Trial
Official title:
Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty
Coronary artery stenting has evolved as an effective treatment for angina and involves
stretching up narrowings within the heart arteries using a balloon (coronary angioplasty)
before implanting a small metal scaffold (stent) to splint the artery open. It is imperative
that stents are fully expanded when they are deployed. If not, then patients are exposed to
the serious risk of a blood clot forming in the stent (stent thrombosis), or the stent
renarrowing (restenosis). One fifth of patients experiencing stent thrombosis will die and
70% will suffer a heart attack. Restenosis is associated with recurrent angina and heart
attacks.
Arguably, visualising stents and ensuring adequate stent expansion is most challenging in
patients with extensive hardening, or calcification, of the heart arteries. Optical
coherence tomography is a novel technique that utilises near-infrared light to look inside
small blood vessels in fine detail. It is 10 times more powerful than the best existing
technique, intravascular ultrasound.
The purpose of this study is to compare the utility of optical coherence tomography with
intravascular ultrasound in patients with heavily calcified heart arteries undergoing
rotational atherectomy and coronary stent insertion. It is hoped that the results of this
pilot study will provide proof-of-principle and justification for a larger clinical trial to
formally assess the role of optical coherence tomography to guide coronary angioplasty and
stenting in patients with heavily calcified coronary arteries.
Twelve patients undergoing rotational atherectomy and coronary stenting for angina in Lothian will be recruited. Rotational atherectomy and stent implantation will be performed as part of routine clinical care. Immediately following stent implantation paired intravascular images of the implanted stent will be obtained using both intravascular ultrasound and optical coherence tomography. The stent will then be further dilated at high pressure with a non compliant balloon and the intravascular images repeated with both intravascular ultrasound and optical coherence tomography. The images obtained will be available to the operator to guide further treatment. ;
Observational Model: Case-Crossover, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Withdrawn |
NCT03134105 -
A Wearable EducAtional Intervention to REduce Angina
|
N/A | |
Completed |
NCT02832115 -
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
|
Phase 4 | |
Completed |
NCT02265796 -
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
|
Phase 2 | |
Terminated |
NCT00221182 -
Stem Cell Study for Patients With Heart Disease
|
Phase 1/Phase 2 | |
Completed |
NCT01721096 -
XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
|
||
Recruiting |
NCT01214499 -
Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina
|
Phase 2 | |
Terminated |
NCT01285297 -
Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction
|
N/A | |
Withdrawn |
NCT00774891 -
Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
|
N/A | |
Completed |
NCT02707783 -
Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
|
||
Completed |
NCT00946725 -
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
|
Phase 1 | |
Recruiting |
NCT02439541 -
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy
|
Phase 1/Phase 2 | |
Completed |
NCT02341664 -
Patient and Provider Assessment of Lipid Management Registry
|
||
Withdrawn |
NCT00657514 -
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
|
Phase 4 | |
Recruiting |
NCT01361659 -
Shockwave Treatment for Advanced Angina in Maastricht
|
N/A | |
Recruiting |
NCT05786417 -
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
|
Phase 4 | |
Withdrawn |
NCT02507050 -
Ivabradine and Post-revascularisation Microcirculatory Dysfunction
|
Phase 4 | |
Active, not recruiting |
NCT02468960 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)
|
N/A | |
Completed |
NCT01086228 -
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
|
N/A | |
Completed |
NCT00824005 -
Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)
|
Phase 2 |